专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

61. 发明申请

WO2007102994A2 SYSTEMS AND METHODS FOR HYDROGEN STORAGE AND GENERATION FROM WATER USING LITHIUM BASED MATERIALS 审中-公开
标题翻译：氢氧储存和使用基于锂的材料从水中产生的系统和方法
公开(公告)号：WO2007102994A2
公开(公告)日：2007-09-13
申请号：PCT/US2007/004592
申请日：2007-02-22
申请人： UNIVERSITY OF UTAH RESEARCH FOUNDATION , FANG, Zhigang, Zak , LU, Jun , SOHN, Hong, Yong
发明人： FANG, Zhigang, Zak , LU, Jun , SOHN, Hong, Yong
IPC分类号： C01D15/00
CPC分类号： C01B3/065 , C01B3/0026 , C01B6/04 , C01D15/02 , C01F5/04 , C22B5/04 , C22B26/12 , Y02E60/327 , Y02E60/362
摘要： A process for forming lithium hydride for use in storing and producing hydrogen is presented. The process includes reacting lithium oxide with water to form a regenerated lithium hydroxide and reacting the regenerated lithium hydroxide with magnesium to form magnesium oxide and a regenerated lithium hydride. The magnesium oxide can be regenerated to form magnesium. The process can further include reacting lithium hydride to form hydrogen and lithium oxide. Such hydrogen production can include reaction between lithium hydride and lithium hydroxide, and/or reaction between lithium hydride and water.
摘要翻译：提出了一种形成用于储存和生产氢的氢化锂的方法。该方法包括使氧化锂与水反应以形成再生的氢氧化锂，并使再生的氢氧化锂与镁反应形成氧化镁和再生的氢化锂。氧化镁可再生以形成镁。该方法还可以包括使氢化锂反应形成氢和氧化锂。这种氢气生成可以包括氢化锂和氢氧化锂之间的反应，和/或氢化锂与水之间的反应。

62. 发明申请

WO2004030621A3 METHOD OF TREATING CANCER USING ADENOSINE AND ITS ANALOGS 审中-公开
标题翻译：使用腺嘌呤及其类似物治疗癌症的方法
公开(公告)号：WO2004030621A3
公开(公告)日：2004-12-09
申请号：PCT/US0330701
申请日：2003-09-30
申请人： UNIV BOSTON , RAVID KATYA , LU JUN
发明人： RAVID KATYA , LU JUN
IPC分类号： A61K31/7076 , A61K31/70
CPC分类号： A61K31/137 , A61K31/56 , A61K31/7076
摘要： The present invention provides methods of treating individuals having malignancies associated with estrogen receptor activity comprising administering to an individual affected with said malignancy, an effective amount of adenosine analog in a pharmaceutical carrier to downregulate or diminish estrogen receptors in the cells. The invention further provides methods of identifying novel adenosine analogues capable of treating malignant cells expressing estrogen receptors. The invention also provides kits comprising adenosine analogs for downregulating estrogen receptors in cells and kits for screening for novel adenosine analogs capable of downregulating estrogen receptors. Further, the invention provides uses of adenosine analogs in downregulation of estrogen receptors, cell growth and cell cycle, as well as pharmaceutical compositions comprising adenosine analogs effective in suppressing cellular growth, cell cycle or downregulating estrogen receptors.
摘要翻译：本发明提供了治疗患有与雌激素受体活性相关的恶性肿瘤的个体的方法，其中包括对受到所述恶性肿瘤影响的个体施用有效量的药物载体中的腺苷类似物以下调或减少细胞中的雌激素受体。本发明还提供鉴定能够治疗表达雌激素受体的恶性细胞的新型腺苷类似物的方法。本发明还提供了包含用于下调细胞中雌激素受体的腺苷类似物的试剂盒和用于筛选能够下调雌激素受体的新型腺苷类似物的试剂盒。此外，本发明提供了腺苷类似物在下调雌激素受体，细胞生长和细胞周期中的用途，以及包含有效抑制细胞生长，细胞周期或下调雌激素受体的腺苷类似物的药物组合物的用途。

63. 发明申请

WO2004030621A2 METHOD OF TREATING CANCER USING ADENOSINE AND ITS ANALOGS 审中-公开
标题翻译：用腺苷及其类似物治疗癌症的方法
公开(公告)号：WO2004030621A2
公开(公告)日：2004-04-15
申请号：PCT/US2003/030701
申请日：2003-09-30
申请人： THE TRUSTEES OF BOSTON UNIVERSITY , RAVID, Katya , LU, Jun
发明人： RAVID, Katya , LU, Jun
IPC分类号： A61K
CPC分类号： A61K31/137 , A61K31/56 , A61K31/7076
摘要： The present invention provides methods of treating individuals having malignancies associated with estrogen receptor activity comprising administering to an individual affected with said malignancy, an effective amount of adenosine analog in a pharmaceutical carrier to downregulate or diminish estrogen receptors in the cells. The invention further provides methods of identifying novel adenosine analogues capable of treating malignant cells expressing estrogen receptors. The invention also provides kits comprising adenosine analogs for downregulating estrogen receptors in cells and kits for screening for novel adenosine analogs capable of downregulating estrogen receptors. Further, the invention provides uses of adenosine analogs in downregulation of estrogen receptors, cell growth and cell cycle, as well as pharmaceutical compositions comprising adenosine analogs effective in suppressing cellular growth, cell cycle or downregulating estrogen receptors.
摘要翻译：本发明提供了治疗患有与雌激素受体活性相关的恶性肿瘤的个体的方法，包括向患有所述恶性肿瘤的个体施用有效量的药物载体中的腺苷类似物以下调或减少雌激素受体细胞。本发明还提供了鉴定能够治疗表达雌激素受体的恶性细胞的新型腺苷类似物的方法。本发明还提供了包含用于下调细胞中雌激素受体的腺苷类似物和用于筛选能够下调雌激素受体的新型腺苷类似物的试剂盒的试剂盒。此外，本发明提供腺苷类似物在下调雌激素受体，细胞生长和细胞周期中的用途，以及包含有效抑制细胞生长，细胞周期或下调雌激素受体的腺苷类似物的药物组合物。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式